Clinical Trials Using Autologous CRISPR-Cas9 Engineered Regnase-1/SOCS1 Dual-edited Tumor Infiltrating Lymphocytes KSQ-004EX
Review the clinical trials studying autologous crispr-cas9 engineered regnase-1/socs1 dual-edited tumor infiltrating lymphocytes ksq-004ex on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: M D Anderson Cancer Center, Houston, Texas